The Europe IV hydration therapy market is estimated to be valued at US$ 244.1 million in 2022 and is expected to exhibit a CAGR of 7.2% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
IV hydration therapy involves administering intravenous fluids containing electrolytes, vitamins, and other components for hydration. It is mainly used to treat dehydration, electrolyte imbalances, and acute illnesses. The therapy provides instant hydration and helps improve hydration levels faster than oral rehydration. It is gaining popularity as an effective treatment option for hangovers, jet lags, and preventing illnesses during traveling.
Rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and renal diseases which require IV hydration is a major factor driving the Europe IV hydration therapy market growth. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death in Europe with over 4 million deaths annually in Europe, accounting for nearly 45% of all deaths in the region. Furthermore, increasing adoption of IV hydration therapy as a preventive healthcare and anti-aging treatment option is also fueling market growth. Rising health awareness and growing demand for wellness and preventive care options are projected to offer tremendous growth opportunities over the forecast period. Additionally, increasing cases of influenza, gastroenteritis, and other communicable diseases requiring IV rehydration is positively impacting market growth.
Strength: Quick hydration, cost-effective treatment for dehydration, no side effects compared to oral hydration.
Weakness: Fear of needles, requires frequent visits to clinics for treatment.
Opportunities: Growing health and wellness trends, increasing popularity of IV therapy for hydration.
Threats: Risk of infections from contaminated saline solutions, stringent regulations.
The Europe IV Hydration Therapy Market Size is expected to grow at a CAGR of 7.2% during the forecast period due to the growing popularity of IV therapy as a quick and effective hydration treatment.
The UK dominates the Europe IV hydration therapy market and is expected to maintain its lead during the forecast period. This can be attributed to the widespread availability of IV hydration clinics and growing awareness about health and wellness in the country.
Key players operating in the Europe IV hydration therapy market are REVITA, Ivtherapygreece, IV Boost UK, Harpal Clinic Limited, IV Drips London, VITAMIN INJECTIONS LONDON, Cryojuvenate UK Ltd., Italy Health Retreats, Séchoir, ELIXIR, Swiss Medical Centre, Drip Hydration, REVIV, VITANOVAS, and The IV Doc Inc. These players are focusing on new product launches and partnerships to strengthen their presence in the lucrative European market.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it